AR069356A1 - Tratamiento de disfagia faringea oral - Google Patents
Tratamiento de disfagia faringea oralInfo
- Publication number
- AR069356A1 AR069356A1 ARP080105015A ARP080105015A AR069356A1 AR 069356 A1 AR069356 A1 AR 069356A1 AR P080105015 A ARP080105015 A AR P080105015A AR P080105015 A ARP080105015 A AR P080105015A AR 069356 A1 AR069356 A1 AR 069356A1
- Authority
- AR
- Argentina
- Prior art keywords
- product
- promoting
- individual
- agonist
- vanilloid receptor
- Prior art date
Links
- 208000019505 Deglutition disease Diseases 0.000 title 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 abstract 3
- RBCYRZPENADQGZ-UHFFFAOYSA-N dihydrocapsaicin Natural products COC1=CC(COC(=O)CCCCCCC(C)C)=CC=C1O RBCYRZPENADQGZ-UHFFFAOYSA-N 0.000 abstract 3
- 230000001737 promoting effect Effects 0.000 abstract 3
- 230000011514 reflex Effects 0.000 abstract 3
- 230000009747 swallowing Effects 0.000 abstract 3
- 239000000105 vanilloid receptor agonist Substances 0.000 abstract 3
- BXBVPYSHEOQGHP-UHFFFAOYSA-N Nordihydrocapsiate Chemical compound COC1=CC(COC(=O)CCCCCC(C)C)=CC=C1O BXBVPYSHEOQGHP-UHFFFAOYSA-N 0.000 abstract 2
- 239000000556 agonist Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 239000000835 fiber Substances 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 abstract 2
- IKYCZSUNGFRBJS-UHFFFAOYSA-N Euphorbia factor RL9 = U(1) = Resiniferatoxin Natural products COC1=CC(O)=CC(CC(=O)OCC=2CC3(O)C(=O)C(C)=CC3C34C(C)CC5(OC(O4)(CC=4C=CC=CC=4)OC5C3C=2)C(C)=C)=C1 IKYCZSUNGFRBJS-UHFFFAOYSA-N 0.000 abstract 1
- LGEQQWMQCRIYKG-DOFZRALJSA-N anandamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO LGEQQWMQCRIYKG-DOFZRALJSA-N 0.000 abstract 1
- LGEQQWMQCRIYKG-UHFFFAOYSA-N arachidonic acid ethanolamide Natural products CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCO LGEQQWMQCRIYKG-UHFFFAOYSA-N 0.000 abstract 1
- 229960002504 capsaicin Drugs 0.000 abstract 1
- 235000017663 capsaicin Nutrition 0.000 abstract 1
- ZICNYIDDNJYKCP-SOFGYWHQSA-N capsiate Chemical compound COC1=CC(COC(=O)CCCC\C=C\C(C)C)=CC=C1O ZICNYIDDNJYKCP-SOFGYWHQSA-N 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- XJQPQKLURWNAAH-UHFFFAOYSA-N dihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCCC(C)C)=CC=C1O XJQPQKLURWNAAH-UHFFFAOYSA-N 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- MLJGZARGNROKAC-VQHVLOKHSA-N homocapsaicin Chemical compound CCC(C)\C=C\CCCCC(=O)NCC1=CC=C(O)C(OC)=C1 MLJGZARGNROKAC-VQHVLOKHSA-N 0.000 abstract 1
- JKIHLSTUOQHAFF-UHFFFAOYSA-N homocapsaicin Natural products COC1=CC(CNC(=O)CCCCCC=CC(C)C)=CC=C1O JKIHLSTUOQHAFF-UHFFFAOYSA-N 0.000 abstract 1
- JZNZUOZRIWOBGG-UHFFFAOYSA-N homocapsaicin-II Natural products COC1=CC(CNC(=O)CCCCC=CCC(C)C)=CC=C1O JZNZUOZRIWOBGG-UHFFFAOYSA-N 0.000 abstract 1
- 230000036571 hydration Effects 0.000 abstract 1
- 238000006703 hydration reaction Methods 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- DSDNAKHZNJAGHN-UHFFFAOYSA-N resinferatoxin Natural products C1=C(O)C(OC)=CC(CC(=O)OCC=2CC3(O)C(=O)C(C)=CC3C34C(C)CC5(OC(O4)(CC=4C=CC=CC=4)OC5C3C=2)C(C)=C)=C1 DSDNAKHZNJAGHN-UHFFFAOYSA-N 0.000 abstract 1
- DSDNAKHZNJAGHN-MXTYGGKSSA-N resiniferatoxin Chemical compound C1=C(O)C(OC)=CC(CC(=O)OCC=2C[C@]3(O)C(=O)C(C)=C[C@H]3[C@@]34[C@H](C)C[C@@]5(O[C@@](O4)(CC=4C=CC=CC=4)O[C@@H]5[C@@H]3C=2)C(C)=C)=C1 DSDNAKHZNJAGHN-MXTYGGKSSA-N 0.000 abstract 1
- 229940073454 resiniferatoxin Drugs 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Botany (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Tea And Coffee (AREA)
- Medicinal Preparation (AREA)
Abstract
Reivindicacion 1: Un producto nutricional o medicinal liquido administrable por vía oral caracterizada porque comprende: al menos un agonista del receptor vainilloide 1 (VR-1) capaz de promover un reflejo de deglucion en un individuo. Reivindicacion 2: Un producto de hidratacion líquido administrable por vía oral caracterizada porque comprende: al menos un agonista del receptor vainilloide 1 (VR-1) capaz de promover un reflejo de deglucion en un individuo. Reivindicacion 3: Un producto alimenticio de textura modificada caracterizado porque comprende: al menos un agonista del receptor vainilloide 1 (VR-1) capaz de promover un reflejo de deglucion en un individuo. Reivindicacion 4: El producto de la reivindicacion 1, 2, o 3, caracterizado porque al menos un agonista de VR-1 no es pungente. Reivindicacion 5: El producto de la reivindicacion 1, 2, o 3, caracterizada porque al menos un agonista de VR-1 se selecciona del grupo que consiste en: capsaicina, capsiato, dihidrocapsaicina, dihidrocapsiato nordihidrocapsaicina, nordihidrocapsiato, homocapsaicina, homodihidrocapsaicina, vanillilamida de ácido n-nonanoico (VNA), anandamida, resiniferatoxina y olvanilo. Reivindicacion 6: El producto de la reivindicacion 1, 2, o 3, caracterizado porque además comprende al menos uno de los siguientes: una proteína, una fibra soluble, una fibra insoluble, un ácido graso, una vitamina, un mineral, un azucar, un carbohidrato, un agente saborizante, un medicamento y un agente terapéutico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98893007P | 2007-11-19 | 2007-11-19 | |
US2289908P | 2008-01-23 | 2008-01-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR069356A1 true AR069356A1 (es) | 2010-01-13 |
Family
ID=40139229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080105015A AR069356A1 (es) | 2007-11-19 | 2008-11-18 | Tratamiento de disfagia faringea oral |
Country Status (19)
Country | Link |
---|---|
US (1) | US8871281B2 (es) |
EP (2) | EP2578213A1 (es) |
JP (2) | JP2011504172A (es) |
CN (1) | CN101848709A (es) |
AR (1) | AR069356A1 (es) |
AU (1) | AU2008326640C1 (es) |
BR (1) | BRPI0819342A2 (es) |
CA (1) | CA2705836C (es) |
CL (1) | CL2008003438A1 (es) |
DK (1) | DK2222289T3 (es) |
ES (1) | ES2430043T3 (es) |
HK (1) | HK1142010A1 (es) |
MX (1) | MX2010005465A (es) |
PT (1) | PT2222289E (es) |
RU (2) | RU2481829C2 (es) |
SG (1) | SG188167A1 (es) |
TW (1) | TWI426899B (es) |
WO (1) | WO2009067296A1 (es) |
ZA (1) | ZA201004333B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009067296A1 (en) | 2007-11-19 | 2009-05-28 | Nestec S.A. | Treatment of oral pharyngeal dysphagia |
ES2936634T3 (es) | 2013-02-08 | 2023-03-21 | Gen Mills Inc | Productos alimenticios reducidos en sodio |
AU2014295230A1 (en) | 2013-07-22 | 2015-12-17 | Nestec S.A. | Compositions and methods using tiglic aldehyde |
JP6879297B2 (ja) * | 2016-04-13 | 2021-06-02 | 味の素株式会社 | 加齢に伴う身体機能低下もしくは身体機能障害、または加齢に伴う精神機能低下もしくは精神機能障害の抑制または改善用組成物 |
CN108142940B (zh) * | 2018-02-05 | 2021-05-14 | 中山大学附属第三医院(中山大学肝脏病医院) | 一种促吞咽软片及其制备方法 |
WO2020139797A1 (en) * | 2018-12-24 | 2020-07-02 | Sorrento Therapeutics, Inc. | Methods for treating parkinson's disease by administering resiniferatoxin |
RU2714177C1 (ru) * | 2019-07-23 | 2020-02-12 | Федеральное Государственное Бюджетное Научное Учреждение "Федеральный Научно-Клинический Центр Реаниматологии И Реабилитологии" (Фнкц Рр) | Способ лечения крикофарингеальной недостаточности и восстановления функции глотания |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07274915A (ja) * | 1994-03-31 | 1995-10-24 | Taiyo Kagaku Co Ltd | 柔軟性容器入りゼリー様飲料 |
JP3345744B2 (ja) | 1998-03-04 | 2002-11-18 | 森永製菓株式会社 | エステル結合を有する新規なカプサイシノイド様物質 |
AU2001269375A1 (en) * | 2000-05-08 | 2001-11-20 | Forskarpatent I Syd Ab | Anandamide and structurally related lipids as vanilloid receptor modulators |
US7638150B2 (en) * | 2002-08-02 | 2009-12-29 | Simply Thick Llp | Process for preparing concentrate thickener compositions |
US20030082249A1 (en) * | 2001-10-26 | 2003-05-01 | Ovation Pharmaceuticals | Compositions containing capsaicin and its derivatives, and their use in treating mucositis |
GB0221157D0 (en) | 2002-09-12 | 2002-10-23 | Glaxo Group Ltd | Novel treatment |
CN100431553C (zh) * | 2002-12-26 | 2008-11-12 | 株式会社山田养蜂场本社 | 改善咽下障碍用组合物 |
EP2070551B1 (en) * | 2003-01-31 | 2013-01-16 | Simply Thick LLC | Process for producing thickened beverages for dysphagia |
CA2522028C (en) * | 2003-04-10 | 2011-11-01 | Neurogesx, Inc. | Methods and compositions for administration of trpv1 agonists |
US20060182825A1 (en) * | 2005-02-11 | 2006-08-17 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Methods and compounds for the treatment of obesity and obesity-related disorders |
JP4526472B2 (ja) * | 2005-12-02 | 2010-08-18 | 仁敬 越久 | 嚥下障害治療装置 |
MY161865A (en) * | 2006-02-10 | 2017-05-15 | Mannatech Inc | All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization |
JP5245823B2 (ja) * | 2006-04-24 | 2013-07-24 | 味の素株式会社 | 嚥下障害改善剤およびそれを含有する医薬又は食品組成物 |
WO2009067296A1 (en) | 2007-11-19 | 2009-05-28 | Nestec S.A. | Treatment of oral pharyngeal dysphagia |
-
2008
- 2008-10-07 WO PCT/US2008/079044 patent/WO2009067296A1/en active Application Filing
- 2008-10-07 DK DK08852202.4T patent/DK2222289T3/da active
- 2008-10-07 BR BRPI0819342-8A patent/BRPI0819342A2/pt not_active Application Discontinuation
- 2008-10-07 US US12/743,363 patent/US8871281B2/en active Active
- 2008-10-07 ES ES08852202T patent/ES2430043T3/es active Active
- 2008-10-07 CN CN200880114767A patent/CN101848709A/zh active Pending
- 2008-10-07 EP EP12197207.9A patent/EP2578213A1/en not_active Withdrawn
- 2008-10-07 MX MX2010005465A patent/MX2010005465A/es active IP Right Grant
- 2008-10-07 SG SG2013012281A patent/SG188167A1/en unknown
- 2008-10-07 RU RU2010125285/15A patent/RU2481829C2/ru not_active IP Right Cessation
- 2008-10-07 EP EP08852202.4A patent/EP2222289B1/en active Active
- 2008-10-07 CA CA2705836A patent/CA2705836C/en active Active
- 2008-10-07 AU AU2008326640A patent/AU2008326640C1/en active Active
- 2008-10-07 PT PT88522024T patent/PT2222289E/pt unknown
- 2008-10-07 JP JP2010534072A patent/JP2011504172A/ja active Pending
- 2008-10-24 TW TW097141030A patent/TWI426899B/zh not_active IP Right Cessation
- 2008-11-18 AR ARP080105015A patent/AR069356A1/es not_active Application Discontinuation
- 2008-11-19 CL CL2008003438A patent/CL2008003438A1/es unknown
-
2010
- 2010-06-18 ZA ZA2010/04333A patent/ZA201004333B/en unknown
- 2010-09-10 HK HK10108643.2A patent/HK1142010A1/xx not_active IP Right Cessation
-
2012
- 2012-10-11 JP JP2012226070A patent/JP2013056893A/ja active Pending
-
2013
- 2013-01-23 RU RU2013103032/15A patent/RU2013103032A/ru not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ES2430043T3 (es) | 2013-11-18 |
RU2013103032A (ru) | 2014-07-27 |
PT2222289E (pt) | 2013-09-30 |
AU2008326640A1 (en) | 2009-05-28 |
CN101848709A (zh) | 2010-09-29 |
AU2008326640B2 (en) | 2012-08-23 |
JP2011504172A (ja) | 2011-02-03 |
EP2222289B1 (en) | 2013-08-28 |
AU2008326640C1 (en) | 2013-07-04 |
ZA201004333B (en) | 2011-12-28 |
EP2222289A1 (en) | 2010-09-01 |
CA2705836C (en) | 2014-06-10 |
CL2008003438A1 (es) | 2010-01-11 |
US20110028382A1 (en) | 2011-02-03 |
US8871281B2 (en) | 2014-10-28 |
MX2010005465A (es) | 2010-06-02 |
DK2222289T3 (da) | 2013-10-07 |
HK1142010A1 (en) | 2010-11-26 |
JP2013056893A (ja) | 2013-03-28 |
SG188167A1 (en) | 2013-03-28 |
RU2010125285A (ru) | 2011-12-27 |
WO2009067296A1 (en) | 2009-05-28 |
TWI426899B (zh) | 2014-02-21 |
TW200934479A (en) | 2009-08-16 |
BRPI0819342A2 (pt) | 2015-05-19 |
EP2578213A1 (en) | 2013-04-10 |
RU2481829C2 (ru) | 2013-05-20 |
CA2705836A1 (en) | 2009-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR069356A1 (es) | Tratamiento de disfagia faringea oral | |
WO2011152726A8 (en) | Pre-thickened compact liquid nutritional composition for dysphagia patients | |
CL2018001007A1 (es) | Composiciones farmacéuticas para terapias combinadas (sol. divisional de n° 201702538). | |
AR104835A1 (es) | Composiciones nutricionales que contienen un nivel elevado de inositol y uso de las mismas | |
ES2547122T3 (es) | Composición nutricional de baja concentración | |
CL2013003003A1 (es) | Uso de fórmula infantil que comprende al menos una fuente de proteínas, una fuente de lípidos, una fuente de carbohidratos, con 1,6-1,85 g/100 kcal que sirve para preparar un medicamento útil en la prevención de la presión sanguínea elevada o de las enfermedades cardiovasculares. | |
AR110060A1 (es) | Composiciones nutricionales que proporcionan el manejo dietético de cólicos | |
Jiang et al. | Early enteral nutrition for upper digestive tract malformation in neonates | |
Casas et al. | Adapted ice cream as a nutritional supplement in cancer patients: impact on quality of life and nutritional status | |
AR110344A1 (es) | Métodos y regímenes de alimentación que comprenden la administración de composiciones nutricionales que contienen butirato dietario | |
UY31662A1 (es) | Composiciones de tabletas de ranitidina de desintegracion oral y sus metodos de elaboracion. | |
AR063891A1 (es) | Composicion para ser usada en productos alimenticios, preparados nutricionales, nutraceuticos y farmaceuticos | |
CO2017006985A2 (es) | Producto de administración oral | |
WO2011137322A3 (en) | Methods and compositions for treating celiac disease | |
Kaur et al. | Innate antioxidant activity of some traditional formulations | |
Bele et al. | An approach to a Nutraceutical | |
CL2022003426A1 (es) | Composición farmacéutica acuosa de levilimab y su uso | |
NZ712924A (en) | Use of a dietary fibre supplement in a food formulation | |
CL2020002369A1 (es) | Preparación farmacéutica o de complemento alimenticio a base de alfa-lactoalbúmina | |
JP2008017813A (ja) | 酢を含有する錠剤食品 | |
Mahdinejadiani et al. | An Evaluation the Effect of Glycyrrhetinic and Glycyrrhizic Acids Derived from Licorice Extract on Gastric Cancer Cell Lines | |
Kan | Therapeutic effect of a chitin oligosaccharide mixture by per os administration on human cancer | |
Matuchansky | incidence rates of Barrett's oesophagus and oesophageal adenocarcinoma in the UK and the Netherlands. | |
TH171960A (th) | องค์ประกอบในรูปอนุภาคที่ช่วยแตกตัวซึ่งประกอบด้วยไมโครไฟบริลเลเทดเซลลูโลส | |
JP2024057701A (ja) | Il-6レセプター抑制剤を含む、シミ形成阻害またはシミ改善組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |